Novo Nordisk said Thursday that the rampant growth of the U.S.' compounded drug industry was hurting Wegovy sales, and warned ...

Bank of America analysts on Friday said Novo Nordisk may miss first-quarter expectations, as sales of its blockbuster Wegovy ...

The results pave the way for Rybelsus to become a new treatment option for people living with diabetes and established heart ...

Novo Nordisk has been accepted back into the fold. Two years after suspending Novo, the Association of the British Pharmaceutical Industry (ABPI) has reinstated the Danish drugmaker after seeing ...

Let's take Novo Nordisk's news items one at a time ... Hims & Hers Health stock is continuing to gain strength on the back of reports out last week, that the company's exit from the GLP-1 market ...

Novo Nordisk may be reorganizing its early-stage R&D capabilities, but the Danish pharma’s chief scientific officer has insisted that the changes aren’t primarily about laying off staff. | Novo ...

In this article, we are going to take a look at where Novo Nordisk A/S (NYSE ... And we’re starting to get to levels where you look back and say, “Is this 1989? Is this a period of time ...

March is National Kidney Month – a time to raise awareness and learn more about kidney health and kidney disease. Earlier in ...